產品資訊 - Lurasidone intermediate cas 2746-19-2->active pharmaceutical ingredient

登入

加入會員

求助

JinanJianfengChemicalCo.,Ltd.

	Recommended Results

Lurasidone intermediate cas 2746-19-2

產品分類 :

化學->活性醫療成份

產品規格

Country

產品描述

Chemical Name: CIS-5-NORBORNENE-EXO-2,3-DICARBOXYLIC ANHYDRIDE 
Molecular Formula: C9H8O3 
Formula Weight: 164.16 
CAS No.: 2746-19-2


 <img src="http://i.bosscdn.com/product/3d/05/10/4f12a787b97185f30f06d76f30.gif" title="2746-19-2" alt="2746-19-2" />


Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia in a number of countries including the UK, and is also approved in the USA and Canada for the treatment of major depressive episodes associated with bipolar I disorder as either a monotherapy or adjunctive therapy with lithium or valproate. In addition to full antagonist activity at dopamine D2 (Ki(D2) = 1 nM) and serotonin 5-HT2A (Ki(5-HT2A) = 0.5 nM) receptors, the pharmacodynamic profile of lurasidone is notable for its high affinity for serotonin 5-HT7 receptors (Ki(5-HT7) = 0.5 nM) and its partial agonist activity at 5-HT1A receptors (Ki(5-HT1A) = 6.4 nM). Long-term treatment of schizophrenia with lurasidone has been shown to reduce the risk of relapse. Lurasidone appears associated with minimal effects on body weight and low risk for clinically meaningful alterations in glucose, lipids or electrocardiogram parameters.


 
pharmachemm.com

其他類似產品